Fairchem Organics Ltd Q1 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/ndaom859rvm8nptrgscmwbuw.pdf

Key Takeaways


The Quarter: Realization Surge on Import Relief

Nahoosh Jariwala: "Basically, there was dumping happening from China, which has gone down. And if dumping starts again, we cannot do anything about it."

The Dumping Overhang: Margin Structure and Risk

Nahoosh Jariwala: "It will be something which is happening in China. What type of thought process is going on there? So, I might say that yes, this is sustainable. It might not and it might remain sustainable also. So, I mean, this is a business risk. So, that is one of the reasons we are not doing any crazy expansion or we are not taking any debt or anything."

Isostearic Acid: The Strategic Differentiator

Nahoosh Jariwala: "The beauty is that only third manufacturer in the world. So, it also would have its own entry barrier because the products are used in cosmetics in Europe and Japan which are very, very, very strict companies to deal with. So, that is taking more time. But once you enter, it's a long-term association with them. So, that's fine with us. We don't mind."

New Products and Capacity: Known Unknowns

Nahoosh Jariwala: "Difficult to manufacture. Difficult to manufacture."

Volume Ramp and Market Positioning

Nahoosh Jariwala: "I would not like to enter into any long-term contract with so much volatility. It would be hara-kiri for me."

R&D and Cost Optimization

Nahoosh Jariwala: "R&D is something which takes pretty long and in which time span is not fixed... none of these technologies are available off the shelf. All these technologies are to be self-developed. So, rather than taking any undue risk, we try to move slowly."

Guidance & Commitments

CommitmentSpecificsTimeline
Revenue and margin run rateMaintain similar revenue and margin run rate as Q1 FY27Rest of FY27 (three quarters)
Capacity utilization exit rateReach 70–75% utilization from current ~60%FY27 exit
Quarterly quantity growthGrow quantity 5–7% QoQ, cumulating to 15–20% growthBy Q4 FY27
Isostearic acid capacity utilizationReach >80% capacity utilizationNext 1–2 years
New raw material introductionIntroduce one new raw material manufactured for first timeQ2 FY27
40,000 MT new capacityTrial run starting, ramp-up after stabilization; margins expected better than currentRamp-up timeline not specified
Strategic product mix shiftMove into products that are difficult to manufacture, not application-specificNext 2–3 years
Isostearic acid buyer breakthroughExpect some positive outcomeBy end of FY27 (VAGUE-TIMELINE)

Key Metrics

MetricQ1 FY27
Revenue from operations₹176 crores, +34.4% YoY
EBITDA₹18 crores
EBITDA margin10.14%
Net profit₹10 crores
Sales volume13,500 tonnes, vs 13,000 tonnes in Q1 FY26
Raw material processed12,400 tonnes
Realization growth+30% YoY, +25% QoQ
Capacity utilization~60%, target to exit FY27 at 70-75%
Revenue mix: Dimer acid~30% of revenue
Revenue mix: Linoleic acid42% of revenue
Revenue mix: Isostearic acid4% of revenue
Revenue mix: Other by-products24% of revenue
Export revenue contribution7-8% of revenue
Domestic paint industry revenue40% of domestic revenue
Isostearic acid capacity utilization target>80% in next 1-2 years
Quantity growth target5-7% per quarter, 15-20% by Q4 FY27